Home › Funds › READYSTATE ASSET MANAGEMENT LP › LMAT

READYSTATE ASSET MANAGEMENT LP position in LMAT

LEMAITRE VASCULAR INC COM · Health Care

READYSTATE ASSET MANAGEMENT LP reported holding 20,000,000 shares of LMAT (LEMAITRE VASCULAR INC COM) in its Q2 2026 13F filing — a position valued at US$21.3M, representing 1.03% of its reported portfolio and ranking #24 among its reported holdings. READYSTATE ASSET MANAGEMENT LP has disclosed LMAT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)20.00M sh
Reported value held$21.26M
Portfolio Weight1.03%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How READYSTATE ASSET MANAGEMENT LP's LMAT position evolved

READYSTATE ASSET MANAGEMENT LP first disclosed a stake in LMAT in Q4 2025 at 25,750,000 shares (US$25.8M). Across 3 filings, READYSTATE ASSET MANAGEMENT LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 20,000,000 shares valued at US$21.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 25.75M $25.81M New
Q1 2026 20.00M $22.68M Reduce
Q2 2026 20.00M $21.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LMAT and 13F data

LMAT (LEMAITRE VASCULAR INC COM) is a Health Care company. 39 other funds we track also report a position in LMAT — the largest reported positions include Conestoga Capital Advisors, LLC (US$131.2M), Copeland Capital Management, LLC (US$76.3M), GENEVA CAPITAL MANAGEMENT LLC (US$56.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LMAT

All LMAT fund holders →

FAQ

How long has READYSTATE ASSET MANAGEMENT LP held LMAT?

READYSTATE ASSET MANAGEMENT LP has disclosed LMAT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is READYSTATE ASSET MANAGEMENT LP's current position in LMAT?

As of Q2 2026, READYSTATE ASSET MANAGEMENT LP holds 20.00M shares of LMAT (LEMAITRE VASCULAR INC COM), valued at $21.26M, representing 1.03% of its reported portfolio and ranking #24.

Has READYSTATE ASSET MANAGEMENT LP been buying or selling LMAT?

In the latest 13F filing (Q2 2026), READYSTATE ASSET MANAGEMENT LP held unchanged its position in LMAT.

Which other funds hold LMAT?

Other major institutional holders of LMAT include Conestoga Capital Advisors, LLC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.